Komipharm International Co., Ltd. Stock: price and insider trades · South Korea
코미팜
1 insider bought €28k of shares over the last 90 days, the latest by 박용남, filed 27 Oct 2026.
Komipharm International Co., Ltd.: what insiders have been doing
Komipharm International Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through DART (FSS). The last twelve months, up to 1 November 2026, brought 2 filings signed by 2 insiders.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. The amount is not disclosed for 1 filing. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. On the buying side, the filings list 1 board member among the declarants.
The clock since the last published purchase (27 October 2026) now reads 14 days.
Compared with its exchange (2,655 companies, median 7 filings), a count of 2 filings is below the norm. The full history, which starts in 2021, counts 30 purchases against 8 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,740 sharesShareKRXDART:20261027000059Canonical exit: 25 Jan 2027 (T+90)
- ●Executives0DART
- 3,833,215 sharesKRXDART:20250908000274Canonical exit: 1 Dec 2025 (T+90)
- ●Executives0DART
- 21,700 sharesShareKRXDART:20250107000291Canonical exit: 7 Apr 2025 (T+90)
- 15,000 sharesShareKRXDART:20241230000193Canonical exit: 30 Mar 2025 (T+90)
- 16,109 sharesShareKRXDART:20241227000296Canonical exit: 27 Mar 2025 (T+90)
- 4,444 sharesShareKRXDART:20241118000205Canonical exit: 16 Feb 2025 (T+90)
- 9,740 sharesShareKRXDART:20241114002938Canonical exit: 12 Feb 2025 (T+90)
- 50,133 sharesShareKRXDART:20241114002878Canonical exit: 12 Feb 2025 (T+90)
- ShareKRXDART:20241113000307Canonical exit: 4 Feb 2025 (T+90)
- 8,965 sharesShareKRXDART:20241105000152Canonical exit: 3 Feb 2025 (T+90)
- ShareKRXDART:20241104000145Canonical exit: 26 Jan 2025 (T+90)
- 10,841 sharesKRXDART:20241002000536
- 5,100 sharesShareKRXDART:20240416000232Canonical exit: 14 Jul 2024 (T+90)
- ●Executives0DART
- 10,841 sharesKRXDART:20231220000526
- ShareKRXDART:20231220000017Canonical exit: 18 Mar 2024 (T+90)
- ShareKRXDART:20231219000029Canonical exit: 17 Mar 2024 (T+90)
- 10,841 sharesKRXDART:20231017000337
- 10,841 sharesKRXDART:20231017000316
- ShareKRXDART:20230908000424Canonical exit: 16 Nov 2023 (T+90)
- ShareKRXDART:20230908000407Canonical exit: 16 Nov 2023 (T+90)
- ShareKRXDART:20230908000415Canonical exit: 16 Nov 2023 (T+90)
- ShareKRXDART:20230908000400Canonical exit: 19 Oct 2023 (T+90)
25 of 45 declarations
About Komipharm International Co., Ltd.
코미팜 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
